Synlett 2008(11): 1647-1650  
DOI: 10.1055/s-2008-1077879
LETTER
© Georg Thieme Verlag Stuttgart · New York

Gold(I)-Catalyzed Hydroamination as a General Approach toward the Synthesis of Substituted Hydroisoquinolines: Remarkable Acceleration by Ethanol

Taro Enomoto, Shingo Obika, Yoshizumi Yasui, Yoshiji Takemoto*
Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
Fax: +81(75)7534569; e-Mail: takemoto@pharm.kyoto-u.ac.jp;
Further Information

Publication History

Received 13 March 2008
Publication Date:
11 June 2008 (online)

Abstract

Construction of 1,2-dihydroisoquinolines and 1-alkylidenyl-1,2,3,4-tetrahydroisoquinolines through cationic gold(I) complex catalyzed hydroamination of the corresponding alkynyl carbamates has been demonstrated. In the presence of EtOH, the reaction proceeded smoothly at room temperature with low catalyst loading (1-3 mol%).

4

For examples of 1,2-dihydroisoquinoline syntheses, see references cited in ref 2.

10

The corresponding 5-exo cyclized products, namely isoindoles, were not detected in this work, presumably due to their instability.

11

Structure of 2a was fully confirmed by spectroscopy and by its conversion into known 3-phenylisoquinoline; from 1a,
3-phenylisoquinoline was obtained in 70% yield after cleavage of Boc group (TFA, CH2Cl2, r.t., 30 min) followed by oxidation (I2, KOAc, EtOH, reflux, 1 h).

19

Typical Procedure for the Gold(I)-Catalyzed Hydroamination: To a solution of 1a (309 mg, 1.00 mmol) in DCE (2 mL) were added EtOH (231 mg, 293 µL, 5.02 mmol) and a suspension of AuCl(PPh3) (4.9 mg, 0.0099 mmol) and AgNTf2 (3.8 mg, 0.0098 mmol) in DCE (1 mL) at r.t. After stirring for 2 h, sat. aq NaHCO3 was added and the product was extracted with CHCl3 (3 × 10 mL). The combined organic extracts were washed with brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by silica gel column chromatography (hexane-EtOAc, 25:1) to afford 2a (256 mg, 83%) as colorless crystals: R f 0.70 (hexane-EtOAc, 3:1); mp 105-106 °C. 1H NMR (500 MHz, CDCl3, TMS): δ = 7.48 (d, J = 7.3 Hz, 2 H), 7.36 (dd, J 1 = 7.1 Hz, J 2 = 7.3 Hz, 2 H), 7.30 (t, J = 7.1 Hz, 1 H), 7.18-7.27 (m, 4 H), 6.42 (s, 1 H), 4.89 (s, 2 H), 1.05 (s, 9 H). 13C NMR (126 MHz, CDCl3): δ = 153.0, 140.6, 139.0, 132.7, 132.0, 128.1, 127.7, 127.5, 127.2, 126.3, 125.1, 125.0, 115.2, 81.0, 47.5, 27.6. IR (CHCl3): 1693
cm-1. MS (FAB): m/z = 307 [M+]. Anal. Calcd for C20H21NO2: C, 78.15; H, 6.89; 4.56. Found: C, 78.23; H, 7.07; N, 4.48.
Compound 2e: colorless crystals; R f 0.55 (hexane-EtOAc, 6:1); mp 168-169 °C. 1H NMR (500 MHz, CDCl3, TMS): δ = 7.16-7.26 (m, 4 H), 7.09 (s, 2 H), 6.94 (s, 1 H), 6.41 (s, 1 H), 4.87 (s, 2 H), 2.33 (s, 6 H), 1.06 (s, 9 H). 13C NMR (126 MHz, CDCl3): δ = 153.0, 140.8, 138.7, 137.5, 132.7, 131.9, 129.3, 127.5, 127.0, 125.0, 124.9, 124.1, 114.6, 80.8, 47.5, 27.6, 21.2. IR (CHCl3): 1691 cm-1. MS (FAB): m/z = 335 [M+]. Anal. Calcd for C22H25NO2: C, 78.77; H, 7.51; N, 4.18. Found: C, 78.66; H, 7.50; N, 4.23.
Compound 2h: white powder; R f 0.50 (hexane-EtOAc, 1:1); mp 115-116 °C. 1H NMR (500 MHz, CDCl3, TMS): δ = 7.46 (d, J = 8.2 Hz, 2 H), 7.34 (d, J = 8.2 Hz, 2 H), 7.15-7.26 (m, 4 H), 6.42 (s, 1 H), 4.85 (s, 2 H), 4.68 (s, 2 H), 2.58 (s, 1 H), 1.06 (s, 9 H). 13C NMR (126 MHz, CDCl3): δ = 152.9, 140.6, 140.2, 137.9, 132.5, 131.8, 127.5, 127.2, 126.6, 126.2, 125.0, 124.9, 115.2, 81.0, 64.7, 47.4, 27.6.
IR (CHCl3): 3606, 1693 cm-1. MS (FAB): m/z = 337 [M+]. Anal. Calcd for C21H23NO3: C, 74.75; H, 6.87; N, 4.15. Found: C, 74.47; H, 6.87; N, 3.88.
Compound 4a: colorless needles: R f 0.38 (hexane-EtOAc, 2:1); mp 164-165 °C. 1H NMR (500 MHz, CDCl3, TMS): δ = 7.47 (d, J = 7.6 Hz, 2 H), 7.32 (dd, J 1 = J 2 = 7.6 Hz, 2 H), 7.21 (s, 1 H), 7.19 (t, J = 7.6 Hz, 1 H), 6.74 (s, 1 H), 6.61 (s, 1 H), 4.60 (br, 1 H), 3.97 (s, 3 H), 3.89 (s, 3 H), 3.27 (br, 1 H), 3.13 (br, 1 H), 2.66 (br, 1 H), 1.02 (s, 9 H). 13C NMR (126 MHz, CDCl3): δ = 153.3, 149.3, 147.7, 137.2, 134.0, 128.4, 128.3, 128.0, 126.8, 125.4, 117.6, 111.7, 106.4, 80.3, 56.2, 55.9, 43.0, 28.5, 27.7. IR (CHCl3): 1682 cm-1.
MS (FAB): m/z = 381 [M+]. Anal. Calcd for C23H27NO4: C, 72.42; H, 7.13; N, 3.67. Found: C, 72.38; H, 7.08; N, 3.47.
Compound 4c: colorless crystals; R f 0.38 (hexane-EtOAc, 2:1); mp 146-147 °C. 1H NMR (500 MHz, CDCl3, TMS):
δ = 7.46 (s, 1 H), 7.36 (d, J = 7.8 Hz, 1 H), 7.24 (dd, J 1 = J 2 = 7.8 Hz, 1 H), 7.18 (s, 1 H), 7.17 (d, J = 7.8 Hz, 1 H), 6.68 (s, 1 H), 6.61 (s, 1 H), 4.59 (br, 1 H), 3.96 (s, 3 H), 3.89 (s, 3 H), 3.26 (br, 1 H), 3.12 (br, 1 H), 2.66 (br, 1 H), 1.07 (s, 9 H). 13C NMR (126 MHz, CDCl3): d = 153.0, 149.5, 147.7, 139.1, 135.3, 134.2, 129.5, 128.3, 128.2, 126.7, 126.3, 125.0, 116.0, 111.7, 106.4, 80.6, 56.2, 55.9, 43.1, 28.3, 27.8.
IR (CHCl3): 1685 cm-1. MS (FAB): m/z = 415 [M+]. Anal. Calcd for C23H26ClNO4: C, 66.42; H, 6.30; N, 3.37. Found: C, 66.38; H, 6.32; N, 3.35.